| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Zhou RuijuanExecutive Director | 28.00M | -- | Derivatives acquired | 28.00M | 0.96% |
Changes in interests filed with HKEX by directors and chief executives. The bought/sold totals count long-position purchases and sales only; option exercises, grants and other events are left out.
| Shareholder | |||
|---|---|---|---|
| Wang LiangExecutive Director | 22.11% | 620.30M | |
| Tian YuzeNon-Executive Director | 5.20% | 145.81M | |
| Zhou RuijuanExecutive Director | 0.96% | 28.00M | |
| Du DongExecutive Director | 0.12% | 3.50M | |
| Zhang LeleNon-Executive Director | 0.12% | 3.50M | |
| 賈文杰 | 0.04% | 1.00M | |
| 胡國華 | 0.02% | 500.00K | |
| To Shing ChuenIndependent Non-Executive Director | 0.02% | 500.00K | |
| Cheung Wing PingIndependent Non-Executive Director | 0.02% | 500.00K | |
| Ha Kee Choy EugeneIndependent Non-Executive Director | 0.02% | 500.00K |
From the HKEXnews Disclosure of Interests complete list of directors: each director's long position after their latest filing.
This page shows share dealings filed by TOUYUN BIOTECH (01332) directors and chief executives over the past year (date, shares, price, type and holding afterwards) with bought and sold totals, and each director's current holding. Data comes from the HKEXnews Disclosure of Interests (DI) section.

